ScreenerHero
DC4DexCom, Inc.
XETRA · DE · Healthcare · Medical Devices · dexcom.com
77.60EUR+0.52%Mkt Cap: 31.83B $P/E: 35.60

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States an…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$198.81BUSDP/E 36.9
SYK
STRYKER CORP. R
$120.66BUSDP/E 34.7
SYK
Stryker Corporation
$125.70BUSDP/E 33.9
2M6
Medtronic plc
$111.66BUSDP/E 24.9
BSX
Boston Scientific Corporation
$75.37BUSDP/E 21.1
EW
Edwards Lifesciences Corporation
$53.13BUSDP/E 54.9
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
GEHC
GE HealthCare Technologies Inc. Common Stock
$33.94BUSDP/E 17.2
DXCM
DexCom, Inc.
$33.92BUSDP/E 35.5
PHIA
Koninklijke Philips N.V.
$25.21BUSDP/E 20.8
ZBH
Zimmer Biomet Holdings, Inc.
$19.21BUSDP/E 24.5
SOON
Sonova Holding AG
$16.48BUSDP/E 26.9
PEN
Penumbra, Inc.
$12.87BUSDP/E 80.5
SN
Smith & Nephew plc
$11.52BUSDP/E 19.9
GMED
Globus Medical, Inc.
$11.86BUSDP/E 22.6
GKOS
Glaukos Corp
$11.18BUSD
EUZ
Eckert & Ziegler Strahlen-und Medizinte AG
$9.89BUSDP/E 16.8
PODD
Insulet Corporation
$10.51BUSDP/E 28.4
BIO
Bio-Rad Laboratories, Inc. Class A
$9.75BUSDP/E 44.3
MASI
Masimo Corporation
$9.42BUSDP/E 44.4

Key Statistics

Company
Market Cap31.83B $
Enterprise Value31.64B $
Revenue (TTM)5.40B $
Gross Profit3.05B $
Net Income (TTM)909.02M $
Revenue/Share13.98 USD
Last Price77.60 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11.0K
CountryDE
SectorHealthcare
IndustryMedical Devices
ISINUS2521311074
Valuation
P/E (Trailing)35.60
P/E (Forward)—
PEG1.71
EV/EBITDA20.75
EV/Revenue5.86
P/S5.97
P/B13.11
EPS (TTM)2.19
EPS (Forward)—
52W Range
77.0037% of range78.60
52W High78.60 EUR
52W Low77.00 EUR
Profitability
Gross Margin60.10%
Oper. Margin24.33%
EBITDA Margin28.24%
Profit Margin17.94%
ROE30.46%
ROA13.19%
Growth
Revenue Growth13.10%
Earnings Growth43.60%
Cash Flow & Leverage
Operating CF1.57B $
CapEx (TTM)395.11M $
FCF Margin20.55%
FCF Yield3.49%
Net Debt-596.30M $
Net Debt/EBITDA-0.39
Balance Sheet
Debt/Equity0.51
Current Ratio1.73
Quick Ratio1.37
Book Value/Sh5.997 EUR
Cash/Share5.160 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split4:1
Split DateJun 13, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.377.36M
Float375.96M
Insiders0.27%
Institutions106.34%
Technical
SMA 5063.00 (+23.2%)
SMA 20058.50 (+32.6%)
Beta1.41
S&P 52W Chg20.80%
Avg Vol (30d)202
Avg Vol (10d)376
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—